32 completed, 3 unknown, 2 terminated, 1 not yet recruiting. 40 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 40 | Completed 32, Unknown 3, Terminated 2, Not yet recruiting 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
Follow Iron: new trials by email Literature Review of Iron trials Research Report on Iron
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multiple Micronutrient Supplementation (MMS) vs IFA Acceptability Crossover Trial Iron Folic Acid Tablets with 60 mg of iron, Multiple Micronutrient Supplements with 60 mg of elemental iron - Pregnancy Related | Phase 3 | Not yet recruiting | George Washington University | 130 | 2027-06-01 | 2026-06-04 |
| Micronutrient Enhancement for Development and Health in Adolescents - The MEDHA Study Iron (60 mg)- folic acid (400 ug) [IFA], Multiple micronutrient supplement [MMS], Multiple micronutrient supplement Plus [MMS+] - Neurodevelopment Outcome, Linear Growth | Phase 3 | Recruiting | Johns Hopkins Bloomberg School of Public Health | 3000 | 2026-09-27 | 2026-10-09 |
| Prevention of Iron Deficiency Anemia Post-delivery Ferric carboxymaltose (FCM) and folic acid tablets, Oral iron tablets and folic acid tablets - Postpartum Anemia | Phase 3 | Completed | NICHD Global Network for Women's and Children's Health | 4857 | 2023-05-30 | 2026-07-01 |
| Effect of Moringa Oleifera Leaf on Hemoglobin Levels in Anemia Moringa oleifera capsules, iron and folic acid supplements - Anemia of Pregnancy | Phase 3 | Completed | Universitas Padjadjaran | 60 | 2022-04-01 | 2023-03-09 |
| School-Based Assessment of Micronutrient Interventions in Adolescents in Burkina Faso Iron and folic acid (IFA), Multiple Micronutrient Supplements (MMS) and loading dose of Iron and Folic Acid (IFA) - Anemia | Phase 3 | Completed | Harvard School of Public Health (HSPH) | 3123 | 2020-12-11 | 2024-05-22 |
| Intravenous Versus Oral Iron Therapy in Hemodialysis Patients Intravenous iron, Oral iron - Hemodialysis Complication, Anemia | Phase 3 | Unknown | Chiang Mai University | 124 | 2020-07-29 | 2020-08-11 |
| Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis Sucrosomial Iron, Oral Iron - Anemia, Iron Deficiency, Ulcerative Colitis | Phase 3 | Unknown | American University of Beirut Medical Center | 30 | 2019-11-04 | 2024-01-31 |
| Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia. Ferrum Lek® (iron (III) hydroxide polymaltosate), 100 mg chewable tablets (Lek d.d., Slovenia), MALTOFER® (iron (III) hydroxide polymaltosate), 100 mg chewable tablets (Vifor S.A., Switzerland) - Mild and Moderate Iron-deficiency Anaemia | Phase 3 | Completed | Sandoz | 267 | 2019-06-27 | 2021-07-12 |
| Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA Ferric carboxymaltose, Ferrous Sulfate - Iron Deficiency Anemia | Phase 3 | Completed | American Regent, Inc. | 79 | 2019-01-31 | 2022-06-22 |
| Daily vs. Every Other Day Oral Iron Supplementation in Patients With Absolute Iron Deficiency Anemia Ferrous Sulfate 300Mg Tablet, Vitamin C 500Mg tablet - Anemia, Iron Deficiency Anemia | Phase 3 | Completed | Sunnybrook Health Sciences Centre | 51 | 2019-01-04 | 2025-02-03 |
| Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents GSK1278863, Iron - Anaemia | Phase 3 | Completed | GlaxoSmithKline | 28 | 2016-08-08 | 2019-12-03 |
| Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis Roxadustat, Epoetin alfa, Darbepoetin alfa - Anemia, End Stage Renal Disease (ESRD) | Phase 3 | Completed | Astellas Pharma Europe B.V. | 838 | 2014-11-21 | 2024-11-27 |
| Intravenous High Dose Iron in Blood Donors ferric carboxymaltose, oral iron - Iron Deficiency | Phase 3 | Completed | Medical University of Graz | 176 | 2014-06-01 | 2016-10-06 |
| Safe and Efficacious Iron for Children in Kenya Low-dose iron as NaFeEDTA, Conventional dose iron as ferrous salt, Placebo - Anaemia | Phase 2 / Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 338 | 2014-06-01 | 2015-04-10 |
| Iron Supplementation for Acute Anemia After Postbariatric Abdominoplasty Intravenous Iron sucrose, Oral Iron - Anemia, Iron-Deficiency, Weight Loss | Phase 3 | Completed | Federal University of São Paulo | 56 | 2014-04-01 | 2017-01-24 |
| Effect of Home-fortification With Sprinkles in Hematologic and Nutritional Status in Preschool Children in Medellín Sachets containing a blend of micronutrients in powder form (Iron, Zinc, Folic Acid, Vitamin A and C), sprinkled onto home made food, placebo - Malnutrition | Phase 3 | Unknown | CES University | 100 | 2013-09-01 | 2013-08-06 |
| A Randomized Trial of Oral Iron Therapy in Fibromyalgia Oral Iron, Oral Placebo - Primary Fibromyalgia | Phase 3 | Completed | Sanjay Gandhi Postgraduate Institute of Medical Sciences | 120 | 2013-04-01 | 2018-04-20 |
| Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma Ulipristal Acetate, Iron - Leiomyomas | Phase 3 | Withdrawn | Watson Pharmaceuticals | 2012-04-01 | 2013-02-07 | |
| Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency Herbal medicine, Iron - Iron Deficiency Anemia | Phase 3 | Completed | Casa Espirita Terra de Ismael | 50 | 2012-01-01 | 2015-02-13 |
| A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease Ferumoxytol, Oral Iron - Iron Deficiency Anemia, Nondialysis-dependent Chronic Kidney Disease | Phase 3 | Terminated | AMAG Pharmaceuticals, Inc. | 14 | 2011-10-17 | 2022-04-28 |
Showing 20 of 40. Sign in to see all of them.
Anemia (22) · Anemia, Iron-Deficiency (10) · Iron Deficiencies (5) · Renal Insufficiency, Chronic (3) · Malnutrition (2) · Perinatal Death (2) · Premature Birth (2) · Birth Weight (1) · Colitis, Ulcerative (1) · Diarrhea (1) · Fatigue (1) · Fibromyalgia (1) · Growth Disorders (1) · Infant Death (1) · Inflammatory Bowel Diseases (1)
AMAG Pharmaceuticals, Inc. (5) · American Regent, Inc. (5) · Vifor Pharma (4) · Johns Hopkins Bloomberg School of Public Health (3) · Universitas Indonesia (2) · Watson Pharmaceuticals (2) · American University of Beirut Medical Center (1) · Astellas Pharma Europe B.V. (1) · CES University (1) · Casa Espirita Terra de Ismael (1) · Centers for Disease Control and Prevention (1) · Chiang Mai University (1) · Federal University of São Paulo (1) · George Washington University (1) · GlaxoSmithKline (1)
United States (15) · Russia (6) · Czechia (5) · Germany (5) · India (5) · Poland (5) · Romania (5) · Austria (4) · Belgium (4) · Croatia (4) · United Kingdom (4) · Bangladesh (3) · France (3) · Serbia (3) · Ukraine (3)
Juergen Floege, MD (2) · Ala Sharara, MD (1) · Alfa Muhihi, PhD (1) · Andrea Pembe, MD, MMed, PhD, FCOG (1) · Blair Wylie, MD, MPH (1) · Christian Breymann (1) · Christopher R Sudfeld, ScD, ScM (1) · Cristian Vargas, MD (1) · Dr Elke Bestel (1) · Dr.Yulia Lin (1) · Emily R Smith, ScD, MPH (1) · Gary Hoel, RPh, PhD (1) · Hans Verhoef, PhD (1)
PMID 22874106, PMID 29656600, PMID 40576086, PMID 15824508, PMID 16316362, PMID 17132678, PMID 17666600, PMID 18525001, PMID 18567277, PMID 18752459, PMID 19176796, PMID 19682342, PMID 20730056, PMID 20730057, PMID 22296075, PMID 22705432, PMID 23303315, PMID 24128336, PMID 24428927, PMID 24457604, PMID 24891437, PMID 25536256, PMID 25985774, PMID 26186135, PMID 26431336, PMID 27068478, PMID 27263403, PMID 27604769, PMID 27769295, PMID 27793204, PMID 28095881, PMID 28339831, PMID 28449690, PMID 28770094, PMID 29391008, PMID 29428785, PMID 29958570, PMID 30981629, PMID 31006806, PMID 32380660, PMID 32844185, PMID 33594802, PMID 35155983, PMID 35265334, PMID 36005278, PMID 36792333, PMID 37716443, PMID 38363466, PMID 39062451, PMID 39145520